State Street Corp Eli Lilly & CO Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, State Street Corp holds 34,506,968 shares of LLY stock, worth $29 Billion. This represents 1.04% of its overall portfolio holdings.

Number of Shares

34,506,968

Previous 34,437,950 0.2%

Holding current value

$29 Billion

Previous $28.4 Billion 5.43%

% of portfolio

1.04%

Previous 1.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$713.71 - $898.95 $49.3 Million - $62 Million	69,018 Added 0.2%	34,506,968 $26.9 Billion
Q1 2025 May 15, 2025	BUY	$725.72 - $929.72 $90 Million - $115 Million	124,043 Added 0.36%	34,437,950 $28.4 Billion
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $336 Million - $430 Million	461,692 Added 1.36%	34,313,907 $26.5 Billion
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $19.6 Million - $24.3 Million	-25,347 Reduced 0.07%	33,852,215 $30 Billion
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $276 Million - $346 Million	-381,004 Reduced 1.11%	33,877,562 $30.7 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $279 Million - $373 Million	471,239 Added 1.39%	34,258,566 $26.7 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $200 Million - $236 Million	380,469 Added 1.14%	33,787,327 $19.7 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $205 Million - $283 Million	-471,559 Reduced 1.39%	33,406,858 $17.9 Billion
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $225 Million - $301 Million	642,274 Added 1.93%	33,878,417 $15.9 Billion
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $149 Million - $175 Million	-478,944 Reduced 1.42%	33,236,143 $11.4 Billion
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $42.6 Million - $49.7 Million	132,615 Added 0.39%	33,715,087 $12.3 Billion
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $49.9 Million - $56.9 Million	168,444 Added 0.5%	33,582,472 $10.9 Billion
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $94.7 Million - $111 Million	-339,894 Reduced 1.01%	33,414,028 $10.8 Billion
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $41.3 Million - $51.3 Million	-175,942 Reduced 0.52%	33,753,922 $9.67 Billion
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $183 Million - $227 Million	813,983 Added 2.46%	33,929,864 $9.37 Billion
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $41.7 Million - $51.4 Million	188,305 Added 0.57%	33,115,881 $7.65 Billion
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $76.1 Million - $98.4 Million	421,475 Added 1.3%	32,927,576 $7.56 Billion
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $158 Million - $205 Million	-962,779 Reduced 2.88%	32,506,101 $6.07 Billion
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $191 Million - $253 Million	-1,466,238 Reduced 4.2%	33,468,880 $5.65 Billion
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $258 Million - $298 Million	-1,762,927 Reduced 4.8%	34,935,118 $5.17 Billion
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $48.2 Million - $58 Million	-353,117 Reduced 0.95%	36,698,045 $6.03 Billion
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $4.41 Billion - $5.46 Billion	37,051,162 New	37,051,162 $5.14 Billion

Others Institutions Holding LLY

# of Institutions

4,452

Shares Held

782M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $798B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Eli Lilly & CO Transaction History